`
`EXHIBIT 2006
`EXHIBIT 2006
`
`
`
`
`
`
`
`Blood Pressure, 2015; Early Online: 1–5
`
` ORIGINAL ARTICLE
`
` Continuous blood pressure measurement using the pulse transit time:
`Comparison to intra-arterial measurement
`
` ANDREAS PATZAK 1 , YURI MENDOZA 2 , HEIKO GESCHE 1 & MARTIN KONERMANN 2
`
` 1 Institut f ü r Vegetative Physiologie, Charit é -Universit ä tsmedizin Berlin, Berlin, Germany, and 2 Department of
`Internal Medicine, Marien-Hospital, Kassel, Germany
`
` Abstract
` Continuous blood pressure (BP) measurement allows the investigation of transient changes in BP and thus may give insights
`into mechanisms of BP control. We validated a continuous, non-invasive BP measurement based on the pulse transit time
`(PTT), i.e. BP PTT , by comparing it with the intra-arterial BP (BP i.a. ) measurement. Twelve subjects (fi ve females and seven
`males) were included. BP i.a. was obtained from the radial artery using a system from ReCor Medical. Systolic and diastolic
`BP were calculated using the PTT (BP PTT , SOMNOscreen ™ ). PTT was determined from the electrocardiogram and the
`peripheral pulse wave. The BP was modulated by application of increasing doses of dobutamine (5, 10, 20 μ g/kg body mass).
`Systolic BP PTT and systolic BP i.a. correlated signifi cantly ( R ⫽ 0.94). The limits of agreement in the Bland—Altman plot
`were ⫾ 19 mmHg; the mean values differed by 1 mmHg. The correlation coeffi cient for the diastolic BP measurements was
` R ⫽ 0.42. The limits of agreement in the Bland—Altman plot were ⫾ 18 mmHg, with a mean difference of 5 mmHg in favour
`of the BP PTT . The study demonstrates a signifi cant correlation between the measurement methods for systolic BP. The results
`encourage the application of PTT-based BP measurement for the evaluation of BP dynamics and pathological BP changes.
`
` Keywords: Blood pressure , pulse transit time , validation
`
` Introduction
`(BP)
` Cuff-based methods of blood pressure
`measurement are widely used and robust. Pathological
`changes in BP can be diagnosed in majority of the
`cases (1,2). Most of these methods work discontinu-
`ously with gaps of some minutes ’ duration between
`consecutive measurements. The sampling rate in
`ambulatory BP monitoring is four times per hour dur-
`ing daytime and two times per hour during night-time.
`However, the detection of transient changes in BP due
`to respiratory events requires BP sampling in the range
`of seconds. Several non-invasive methods have been
`developed with the aim of measuring BP continuously.
`They are mainly based on the principle of Penaz (3,4).
`These cuff-based techniques also have some disadvan-
`tages, which
`limit their application
`in practical
`medicine. The necessity for calibration during the mea-
`surement period, which interrupts the measurement,
`their sensitivity to postural changes and the high price
`hamper their distribution (4,5). A more indirect
`
`method for the determination of BP relies on the
`relation between BP and the pulse wave velocity
`(PWV). Studies have shown a correlation between car-
`diovascular parameters and systolic BP measured using
`the pulse transit time (PTT) in patients with sleep
`apnoea (6,7). Also, a strong correlation between sys-
`tolic BP measured using the PTT and BP measured
`by reference methods was shown in experimental and
`clinical studies (8--10). PWV is a function of arterial
`stiffness, which is affected by several factors including
`BP. Since the arterial vessel status differs individually
`and is infl uenced by vascular age and several diseases
`such as arteriosclerosis, diabetes and other cardiovas-
`cular diseases (11), the determination of absolute BP
`using PTT requires a calibration. Recently, a one-point
`calibration was introduced, which drastically reduces
`the effort of such a procedure in practical medicine
`(8). Although validation studies of the PTT-based
`method have been successfully performed, compari-
`sons of BP determination by PTT with the gold
`
` Correspondence: Prof. Dr. med. A. Patzak, Institut f ü r Vegetative Physiologie, Charit é -Universit ä tsmedizin Berlin, 10117 Berlin, Charit é platz 1, Germany.
`E-mail: andreas.patzak@charite.de
`
` (Received 21 September 2014 ; accepted 10 March 2015 )
`
`ISSN 0803-7051 print/ISSN 1651-1999 online © 2015 Scandinavian Foundation for Cardiovascular Research
`DOI: 10.3109/08037051.2015.1030901
`
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`106
`107
`108
`109
`110
`111
`112
`113
`114
`115
`116
`117
`118
`
`1234567891
`
`0
`11
`12
`[AQ1]
`13
`14
`[AQ2]
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`
`
`
`IBLO_A_1030901.indd 1IBLO_A_1030901.indd 1
`
`
`
`3/27/2015 9:23:50 PM3/27/2015 9:23:50 PM
`
`In Press
`
`
`
`2
`
`A. Patzak et al.
`
`standard of BP measurements are rare (9). We there-
`fore conducted a study where the PTT-based method
`with one-point calibration was validated in comparison
`to intra-arterial measurements. The results suggest the
`applicability of this method for clinical investigations.
`
` Methods
`
` Subjects
`
` Twelve subjects, seven male and fi ve female, aged
`between 21 and 53 years were included in the study
`(Table I). The local ethics committee approved the
`study. The subjects gave written informed consent
`before the test.
`
` Protocol
`
` Measurements were performed in a lying position.
`The BP of the subject was increased by intravenous
`administration of dobutamine into the non-dominant
`arm. Dobutamine was applied in cumulative doses
`of 5, 10 and 20 μ g/kg body mass by changing the
`infusion rate of the infusion solution (125 mg dobu-
`tamine/50 ml NaCl 0.9%). Intra-arterial pressure
`was monitored using a 20-gauge catheter, which was
`inserted in the radial artery of the non-dominant
`arm. The catheter was connected by fl uid-fi lled tub-
`ing to a transducer, which was placed at the height
`of the heart. Transducer signals (ReCor Medical,
`Palo Alto, CA, USA) were transferred via an optical
`coupler to a SOMNOscreen ™ device.
` Simultaneously with the intra-arterial measure-
`ment, BP was determined by measuring the PTT using
`the SOMNOscreen. The electrocardiogram (ECG)
`and the fi nger plethysmography curve (dominant arm)
`were recorded with the SOMNOscreen polysomnogra-
`phy device (SOMNOmedics, Randersacker, Germany).
`The determination of PTT and calculation of PWV
`and BP were performed with DOMINO software (sup-
`plied with the SOMNOscreen). A modifi ed lead after
`
`Nehb was applied to obtain the ECG. Two bipolar elec-
`trodes were fi xed parasternally, at the second right
`intercostal space and fi fth left intercostal space. Another
`electrode was affi xed to the lower arm and served as
`the electrical ground. The plethysmography signal was
`obtained using a probe for fi nger plethysmography/ p O 2
`(SOMNOmedics, Randersacker, Germany).
`
` Data processing
`
` Recording and storage of the BP transducer together
`with ECG and plethysmography signal allowed an
`exact temporal alignment of the time series. Systolic
`and diastolic BP values from the intra-arterial record-
`ing were defi ned as the maximum and minimum
`values of the BP waveform following the last detected
`R-peak. Data pairs for systolic and diastolic BP PTT
`and BP i.a. were obtained for each minute of investiga-
`tion. The duration of the protocol was 9 min, result-
`ing in nine data pairs for each subject. PTTs were
`averaged for fi ve cycles to reduce the infl uence of
`respiration on the signal.
`
` Principle of blood pressure detection using pulse transit
`time
`
` PTT is defi ned as the time that a pulse wave needs
`to travel from the left ventricle to a certain site of the
`arterial system. In the present study, PTT results
`from the period between the R-wave of the ECG and
`the appearance of the pulse wave of the same cardiac
`beat at the site of the fi nger plethysmography. PWV
`is calculated as the quotient of the distance (from the
`midline of the breast bone to the fi nger, determined
`using the body correlation factor) and the PTT. The
`DOMINO software calculates the BP on the base of
`a PWV-BP relation and by application of the one-
`point calibration (8). The calibration was performed
`immediately before starting the data collection in
`each patient under resting conditions.
`
` Table I. Characteristics of the subjects and correlation coeffi cients (CC) for systolic (Syst.) and diastolic (Diast.) blood pressure.
`
`Subject no. Gender
`
`Age years) Height (cm)
`
`Body mass (kg)
`
`BMI (kg/m 2 )
`
`CC Syst.
`
`CC Diast. No. of data pairs
`
`1
`M
`23
`2
`M
`21
`3
`F
`25
`4
`M
`27
`5
`F
`37
`6
`M
`53
`7
`F
`27
`8
`F
`33
`9
`M
`29
`10
`F
`26
`11
`M
`23
`12
`M
`22
` M, male; F, female; BMI, body mass index.
`
`191
`180
`187
`177
`161
`169
`185
`173
`163
`183
`183
`163
`
`72
`72
`70
`87
`87
`72
`64
`62
`74
`50
`83
`70
`
`24.1
`22
`22.9
`28.4
`24.9
`23.2
`23.2
`21.0
`23.4
`19.8
`25.6
`22.6
`
`0.959
`0.934
`0.620
`0.912
`0.926
`0.781
`0.872
`0.799
`0.932
`0.937
`0.984
`0.966
`
`0.945
`0.685
`0.666
`0.810
`–0.672
`0.204
`0.679
`0.037
`–0.125
`0.367
`0.852
`0.012
`
`9
`9
`9
`9
`9
`9
`9
`9
`9
`9
`9
`8 * , 9
`
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`106
`107
`108
`109
`110
`111
`112
`113
`114
`115
`116
`117
`118
`
`1234567891
`
`0
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`[AQ4]
`
`
`
`IBLO_A_1030901.indd 2IBLO_A_1030901.indd 2
`
`
`
`3/27/2015 9:23:50 PM3/27/2015 9:23:50 PM
`
`In Press
`
`
`
`
`
` Pulse transit time and blood pressure
`
`3
`
`[AQ3]
`
` Figure 1. Effect of dobutamine on (a) systolic blood pressure and (b) diastolic blood pressure measured intra-arterially (BP i.a., open
`boxes) and using the pulse transit time (BP PTT, grey boxes) presented as box-and-whisker plots: 5th, 25th, 50, 75th and 95th percentiles
`with outliers (dots). Doses 1–3 correspond to 5, 10 and 20 μ g/kg body mass. * Signifi cant difference compared to BP i.a.
`
` Statistics
`
` Data are presented as presented as box-and-whisker
`plots showing 5th, 25th, 50th, 75th and 95th percen-
`tiles, including outliers. The effect of dobutamine on
`the BP was tested using the Kruskal—Wallis test. The
`Mann—Whitney U test was used to test the differ-
`ences between the BP measured by the two methods
`for different doses of dobutamine. The linear rela-
`tionship between BP measured by both methods was
`analysed using Pearson correlation and tested with
`the t distribution. A value of p ⬍ 0.05 was considered
`signifi cant. The Bland—Altman plot was applied for
`investigation of the agreement between the two
`methods.
`
` Results
` Dobutamine treatment increased the systolic and
`diastolic BP i.a. in a dose-dependent manner. Median
`systolic BP rose from 126 mmHg (25th percentile:
`114 mmHg, 75th percentile: 154 mmHg) to 140
`mmHg (123.5 mmHg, 158.5 mmHg) and diastolic
`BP from 63 mmHg (59 mmHg, 70 mmHg) to 66
`mmHg (61.5 mmHg, 70.5 mmHg) in all patients for
`dose 1. The dobutamine doses 2 and 3 further
`elevated systolic BP to 159 mmHg (131 mmHg, 181
`
`mmHg) and 167 mmHg (147 mmHg, 170 mmHg),
`respectively. The values for the diastolic BP i.a. were
`64 mmHg (60 mmHg, 69 mmHg) and 64 mmHg
`(61 mmHg, 67 mmHg), respectively. BP measured
`by PTT changed similarly. The diastolic BP readings
`for doses 1 and 2 were signifi cantly greater than for
`BP i.a. (Figure 1).
` Figure 2(a) shows the scatterplot of systolic BP i.a.
`versus systolic BP PTT for all values measured. The data
`correlated signifi cantly. The correlation coeffi cient was
` R ⫽ 0.947 ( p ⬍ 0.01) and the regression coeffi cient
` R 2 ⫽ 0.896 ( n ⫽ 107) (Figure 2a). Individual correlation
`coeffi cients are given in Table I. The mean difference of
`the systolic BP of both methods was 0.78 mmHg in
`favour of systolic BP PTT and the limits of agreement
`were ⫾ 18.9 mmHg (Bland—Altman plot; Figure 2b).
` Diastolic BP obtained by the two methods cor-
`related less than the systolic BP data. The correlation
`coeffi cient was R ⫽ 0.419 ( p ⬍ 0.01) and the regres-
`sion R ⫽ 0.176 ( n ⫽ 108) (Figure 3a). The individual
`correlation coeffi cients differed clearly (Table I). The
`mean difference between BP i.a. and BP PTT was 4.78
`mmHg, i.e. the BP PTT was greater in the average
`of all measurements. The limits of agreement, also
`depicted in the Bland—Altman plot, were ⫾ 18.05
`mmHg (Figure 3b).
`
` Figure 2. (a) Scatterplot of systolic blood pressure measured i.a. (BPsyst i.a.) versus systolic blood pressure calculated from the pulse
`transit time (BPsyst PTT) for all subjects and measurements. (b) Bland—Altman plot of the systolic blood pressure (BP) data of all
`subjects and measurements ( n 107). The limits of agreement ( ⫾ 1.96 SD) were ⫾ 18.9 mmHg; the mean difference between the methods
`was 0.78 mmHg.
`
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`106
`107
`108
`109
`110
`111
`112
`113
`114
`115
`116
`117
`118
`
`1234567891
`
`0
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`
`
`
`IBLO_A_1030901.indd 3IBLO_A_1030901.indd 3
`
`
`
`3/27/2015 9:23:50 PM3/27/2015 9:23:50 PM
`
`In Press
`
`
`
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`106
`107
`108
`109
`110
`111
`112
`113
`114
`115
`116
`117
`118
`
`4
`
`A. Patzak et al.
`
`BPdiast PTT (mmHg)
`
`BPdiast i.a. (mmHg)
` Figure 3. (a) Scatterplot of diastolic blood pressure measured intra-arterially (BPdiast i.a.) versus diastolic blood pressure calculated from
`the pulse transit time (BPdiast PTT) for all subjects and measurements. (b) Bland—Altman plot of the diastolic blood pressure (BP) data
`of all subjects and measurements (n ⫽ 108). The limits of agreement ( ⫾ 1.96 SD) were ⫾ 18.05 mmHg; the mean difference between the
`methods was 4.78 mmHg.
`
` Discussion
` This study showed that systolic BP measured using
`the PTT and BP measured intra-arterially correlate
`signifi cantly. In the Bland—Altman plot, limits of
`agreement were about 18 mmHg. The correlation of
`diastolic BP values between the methods was
`signifi cant, but clearly smaller compared with the
`systolic BP. Limits of agreement were similar to those
`of the systolic BP in the Bland—Altman plot.
` Non-invasive and continuous BP monitoring
`have attracted increasing attraction because of the
`option to obtain complete time series with high time
`resolution and the ability to access to more informa-
`tion about the BP control systems. Transient changes
`in BP related to respiratory or central nervous system
`events are important for sleep medicine and sleep
`research (12). Fast and transient changes in BP
`cannot be obtained by traditional cuff-based, discon-
`tinuously working methods.
` Based on the fi nding of Moens and Korteweg,
`that the velocity of a longitudinal pressure wave is
`related to the elasticity of the arterial vessel and to
`the vessel dimension (both infl uenced by BP) (13),
`equipment for the indirect measurement of BP has
`been developed. Recent validation studies showed
`encouraging results regarding the applicability of this
`method in medicine (7,9,10,14–16). An important
`aspect in the application of this principle for BP mea-
`surement is the requirement to calibrate the measur-
`ing system (17,18). This is due to the individual
`mechanical properties of the vascular wall, modifi ed
`also by remodelling and arteriosclerosis, which infl u-
`ence the measurement (19–22). To circumvent the
`relevant effort of calibration, which does not fi t the
`clinical situation, a suitable one-point calibration has
`been recently introduced and validated in some stud-
`ies (8–10). However, there is only one study available
`in patients in which the gold standard (intra-arterial
`measurement of BP) was used as the reference method
`(9). In this study, the BP was not actively modulated
`in the subjects. Thus, the relatively small range of BP
`values may limit the signifi cance of the data. The aim
`
`of the present study was to validate the PTT-based
`BP measurement including one-point calibration
`using intra-arterial BP as a reference. The BP was
`elevated by application of dobutamine, which is a
`sympathomimetic,
`inotropic
`agent
`stimulating
` β 1 -receptors (23). It has been shown that dobutamine
`infl uences the cardiovascular system in a similar way
`to physical stimulation (exercise) (17).
` Dobutamine (5, 10 and 20 μ g/kg body mass)
`increased the median systolic BP in all subjects from
`about 126 mmHg to 167 mmHg; individual values
`were between 100 mmHg and 200 mmHg, giving a
`wide range of BP values. Remarkably, the average
`diastolic BP for all subjects changed much less,
`refl ecting the situation of physical load.
` Correlation analysis revealed a highly signifi cant
`relation between systolic BP i.a. and systolic BP PTT . This
`confi rms
`the observations of other
`studies
`(7,8,10,22,24). The mean values differed negligibly
`between the methods. The limits of agreement were 18
`mmHg in the Bland—Altman plot. These observations
`also agree with results from validation studies per-
`formed in healthy volunteers and patients, using the
`same PTT-based method (9). A signifi cant relationship
`between PTT and BP stimulated by dobutamine was
`also observed in anaesthetized mongrel dogs (17).
` The average diastolic BP PTT differed from BP i.a.
`(7.5 mmHg) and the correlation between the meth-
`ods was clearly smaller compared to the situation for
`systolic BP. Correlations varied considerably when
`comparing individuals. Small changes in diastolic BP,
`combined with a variability in BP measurement and
`determination, may be the reason. One can speculate
`that individual factors such as the pattern of the
`plethysmographic curve differ between subjects and
`that this resulted in a higher variability in the obtained
`PTT and PWV. However, this has not been system-
`atically investigated. Greater differences between
`diastolic BP i.a. and diastolic BP PTT have been dem-
`onstrated in a study using the same technique as in
`the present study (9). Both studies also coincide in
`
`1234567891
`
`0
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`
`IBLO_A_1030901.indd 4
`
`3/27/2015 9:23:50 PM
`
`In Press
`
`
`
`
`
` Pulse transit time and blood pressure
`
`5
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`24.
`
` Gesche H , Grosskurth D , Kuchler G , Patzak A . Continuous
`blood pressure measurement by using the pulse transit time:
`comparison to a cuff-based method . Eur J Appl Physiol.
` 2012 ; 112 : 309 – 15 .
` T ,
` Bitter
` H ,
` Schmalgemeier
` D ,
` Bartsch
` S ,
` Ostojic
` Westerheide N , Eckert S , et al . [Validation of continuous
`blood pressure measurements by pulse transit time: a
`comparison with invasive measurements in a cardiac intensive
`care unit] . Dtsch Med Wochenschr . 2010 ; 135 : 2406 – 12 .
` K ,
` Schmalgemeier
` H ,
` Bitter
` T ,
` Bartsch
` S ,
` Bullert
` Fischbach T , Eckert S , et al . Pulse transit time: validation of
`blood pressure measurement under positive airway pressure
`ventilation . Sleep Breath. 2012 ; 16 : 1105 – 12 .
` Mackey RH , Venkitachalam L , Sutton-Tyrrell K . Calcifi ca-
`tions, arterial stiffness and atherosclerosis . Adv Cardiol.
` 2007 ; 44 : 234 – 44 .
` Levy P , Ryan S , Oldenburg O , Parati G . Sleep apnoea and
`the heart . Eur Respir Rev. 2013 ; 22 : 333 – 52 .
` Callaghan FJ , Babbs CF , Bourland JD , Geddes LA . The rela-
`tionship between arterial pulse-wave velocity and pulse fre-
`quency at different pressures .
` J Med Eng Technol.
` 1984 ; 8 : 15 – 8 .
` Zheng YL , Yan BP , Zhang YT , Poon CC . An armband wear-
`able device for overnight and cuff-less blood pressure meas-
`urement . IEEE Trans Biomed Eng. 2014 ; 61 : 2179 – 86 .
` Spiesshofer J , Heinrich J , Bitter T , Efken C , Lehmann R ,
` Eckert S , et al . Validation of blood pressure monitoring using
`pulse
`transit
`time
`in heart
`failure patients with
`Cheyne—Stokes respiration undergoing adaptive servoventi-
`lation therapy . Sleep Breath. 2014 ; 18 : 411 – 21 .
` Nguyen XP , Kronemayer R , Herrmann P , Mejia A , Daw Z ,
` Nguyen XD , et al . Validation of a new non-invasive blood
`pressure measurement method on mice via pulse wave prop-
`agation time measurement on a cuff . Biomed Tech (Berl).
` 2011 ; 56 : 153 – 8 .
` Ochiai R , Takeda J , Hosaka H , Sugo Y , Tanaka R , Soma T .
` The relationship between modifi ed pulse wave transit time
`and cardiovascular changes in isofl urane anesthetized dogs .
` J Clin Monit Comput. 1999 ; 15 : 493 – 501 .
` Barschdoff D , Ehrig M . Kontinuierliche Blutdruckbestim-
`mung wahrend des Belastungs-EKG [Continuous blood
`pressure monitoring during stress ECG] . Biomed Tech (Berl).
` 1998 ; 43 : 34 – 9 .
` Yamashina A , Tomiyama H , Arai T , Koji Y , Yambe M ,
` Motobe H , et al . Nomogram of the relation of brachial-ankle
`pulse wave velocity with blood pressure . Hypertens Res.
` 2003 ; 26 : 801 – 6 .
` Mitchell GF , Parise H , Benjamin EJ , Larson MG , Keyes MJ ,
` Vita JA , et al . Changes in arterial stiffness and wave refl ection
`with advancing age in healthy men and women: the Framing-
`ham Heart Study . Hypertension. 2004 ; 43 : 1239 – 45 .
` Schiffrin EL . Vascular stiffening and arterial compliance .
` Implications for systolic blood pressure. Am J Hypertens.
` 2004 ; 17 : 39 – 48S .
` Foo JY , Lim CS . Pulse transit time as an indirect marker for
`variations in cardiovascular related reactivity . Technol Health
`Care. 2006 ; 14 : 97 – 108 .
` Tuttle RR , Mills J . Dobutamine: development of a new cat-
`echolamine to selectively increase cardiac contractility . Circ
`Res. 1975 ; 36 : 185 – 96 .
` Yamashina A , Tomiyama H , Takeda K , Tsuda H , Arai T ,
` Hirose K , et al . Validity, reproducibility, and clinical signifi -
`cance of noninvasive brachial-ankle pulse wave velocity meas-
`urement . Hypertens Res. 2002 ; 25 : 359 – 64 .
`
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`106
`107
`108
`109
`110
`111
`112
`113
`114
`115
`116
`117
`118
`
`the observation of limits of agreement of the
`Bland—Altman plot in the range of 18–20 mmHg.
` Strengths of the present study are the intra-arte-
`rial BP measurement as a reference and the pharma-
`cological modulation of the BP. However, this study
`also has some limitations. The small number of sub-
`jects constrains the signifi cance of the results. The
`volunteers were relatively young and did not suffer
`from cardiovascular diseases. More validation in
`patients with different diagnoses should be performed
`before the introduction of the method into clinical
`use. Furthermore, the time-frame of measurement in
`the present study is relatively short, which does not
`allow long-term investigation of the BP PTT .
` In conclusion, the present study demonstrates
`that measurement of BP using PTT offers a method
`for monitoring the systolic BP under clinical condi-
`tions. The systolic BP PTT shows a very good correla-
`tion with the gold standard of BP measurement.
`Furthermore, mean values did not differ and the lim-
`its of agreement in the Bland—Altman plot encour-
`age further optimization of the PTT-based method
`with one-point calibration.
`
`interest: A. Patzak advises
` Declaration of
`SOMNOmedics in development of methods for
`blood pressure measurement and has received hono-
`raria and travel support. The study was not supported
`by funding.
`
`2.
`
`3.
`
`4.
`
` References
` Parati G , Ochoa JE , Lombardi C , Salvi P , Bilo G . Assessment
`1.
`and interpretation of blood pressure variability in a clinical
`setting . Blood Press. 2013 ; 22 : 345 – – 54 .
` Zanchetti A . The role of ambulatory blood pressure monitor-
`ing in clinical practice . Am J Hypertens. 1997 ; 10 : 1069 – 80 .
` Penaz J , Voigt A , Teichmann W . Beitrag zur fortlaufenden indi-
`rekten Blutdruckmessung . Z Innere Med. 1976 ; 31 : 1030 – 3 .
` Molhoek GP , Wesseling KH , Settels JJ , van Vollenhoven E ,
` Weeda HW , de Wit B , et al . Evaluation of the Penaz servo-
`plethysmo-manometer
`for the continuous, non-invasive
`measurement of fi nger blood pressure . Basic Res Cardiol.
` 1984 ; 79 : 598 – 609 .
` Kurki T , Smith NT , Head N , Dec-Silver H , Quinn A .
` Noninvasive continuous blood pressure measurement from
`the fi nger: optimal measurement conditions and factors
`affecting reliability . J Clin Monit. 1987 ; 3 : 6 – 13 .
` Pitson DJ , Stradling JR . Value of beat-to-beat blood pressure
`changes, detected by pulse transit time, in the management
`of the obstructive sleep apnoea/hypopnoea syndrome . Eur
`Respir J. 1998 ; 12 : 685 – 92 .
` Hennig A , Gesche H , Fietze I , Penzel T , Glos M , Patzak A .
` Messung von apnoebezogenen Blutdruck ä nderungen mittels
`Pulstransitzeit und Penaz-Prinzip . Atemwegs- und Lungenk-
`rankheiten. 2012 ; 38 : 1 – 8 .
`
`5.
`
`6.
`
`7.
`
`1234567891
`
`0
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`
`
`
`IBLO_A_1030901.indd 5IBLO_A_1030901.indd 5
`
`
`
`3/27/2015 9:23:51 PM3/27/2015 9:23:51 PM
`
`In Press
`
`